Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative disease.

Thrombosis research - 1 Jun 2012

Linnemann Birgit, Kraft Christiane, Roskos Martin, Zgouras Dimitrios, Lindhoff-Last Edelgard

Abstract excerpt

BACKGROUND: Splanchnic vein thrombosis (SVT) is a typical manifestation of polycythaemia vera (PV) or essential thrombocythaemia (ET). The recently discovered JAK2V617F somatic mutation is closely associated with chronic myeloproliferative disease (CMD). We investigated whether thrombosis involving the inferior vena cava (IVC) is also related to the JAK2V617F mutation or CMD. METHODS: Blood samples were obtained...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Chronic Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Risk Factors

Share to Venous Thrombosis

Share to Young Adult

Source

Identifiers

PMID: 21982959
DOI: 10.1016/j.thromres.2011.09.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative disease.PMID 21982959Read ↗

Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders.Semantic proximity Read ↗

Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review.Semantic proximity Read ↗

Combined venous and arterial thrombosis revealing underlying myeloproliferative disorder in a young patient: a case report.Semantic proximity Read ↗

Is the JAK2 V617F mutation a hallmark for different forms of thrombosis?Semantic proximity Read ↗

Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders.Semantic proximity Read ↗

[Thrombosis in myeloproliferative neoplasms].Semantic proximity Read ↗

Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms.Semantic proximity Read ↗

Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis.Semantic proximity Read ↗

The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.Semantic proximity Read ↗

JAK2 mutations across a spectrum of venous thrombosis cases.Semantic proximity Read ↗

JAK2V617F mutation in patients with thrombosis: to screen or not to screen?Semantic proximity Read ↗

Untitled literature recordSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.